Physician profile
Andre Kasko
NPI 1679624191
$507.57
in general payments reported to CMS, 2019-2025
13 companies · $50.84 in 2025
The $50.84 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $160 · 2022: $74.38 · 2023: $90.21 · 2024: $133 · 2025: $50.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $273.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $86.05 | 2022-2024 | Yupelri |
| Gilead Sciences, INC. | $75.94 | 2021 | |
| Sage Therapeutics, LLC | $74.17 | 2024 | |
| Dexcom, INC. | $50.84 | 2025 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $45.93 | 2021-2023 | Mounjaro |
| Abbvie INC. | $44.61 | 2021 | |
| Sanofi Pasteur INC. | $25.23 | 2023 | |
| Pfizer INC. | $22.71 | 2023 | |
| Novo Nordisk INC | $20.12 | 2022 | |
| Organon LLC | $18.49 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.48 | 2024 | |
| Abbott Laboratories | $13.39 | 2022 | |
| Glaxosmithkline, LLC. | $11.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andre Kasko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.